Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09OOC
|
|||
| Former ID |
DIB015054
|
|||
| Drug Name |
Gp100
|
|||
| Synonyms |
DNA vaccine (melanoma), NCI; Gp100 (209-2M); Vaccine (cancer), NCI; DNA vaccine (melanoma), Vical/NCI
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 3 | [1] | |
| Company |
National Cancer Institute
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H10ClF2N3S
|
|||
| Canonical SMILES |
C1=CC(=C(C(=C1)F)CCN2C3=C(C=CC(=N3)Cl)NC2=S)F
|
|||
| InChI |
1S/C14H10ClF2N3S/c15-12-5-4-11-13(19-12)20(14(21)18-11)7-6-8-9(16)2-1-3-10(8)17/h1-5H,6-7H2,(H,18,21)
|
|||
| InChIKey |
RTZACTFZGJNCLF-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00019682) Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.